<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We reviewed the outcome in 15 consecutive patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with a median age of 23 years who received matched sibling peripheral blood stem cell transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>Conditioning regimen was <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (Cy)+anti-thymocyte globulin (ATG) </plain></SENT>
<SENT sid="2" pm="."><plain>Cumulative incidence of transplant related mortality, graft failure, <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD were 20%, 33%, 25%, and 8.3%, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Conditioning with Cy only, resulted in higher rejection rate compared to Cy plus ATG (75% versus 12.5%, p=0.03) </plain></SENT>
<SENT sid="4" pm="."><plain>Eighty percent of patients are alive with a median follow-up of 19.5 (4.6-35.6) months </plain></SENT>
<SENT sid="5" pm="."><plain>Two of the three patients who were re-transplanted with fludarabine had sustained donor chimerism </plain></SENT>
</text></document>